Identification and validation of Novel Estrogen Biosynthesis Biomarkers in Sinonasal Inverted Papilloma
2025

New Biomarkers for Sinonasal Inverted Papilloma

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): Yang Yi-Fang, Yu Sung-Huan, Liao Jia-Bin, Lin Yu-Hsuan

Primary Institution: Kaohsiung Veterans General Hospital

Hypothesis

The study aims to identify and validate novel estrogen biosynthesis biomarkers in sinonasal inverted papilloma (SNIP).

Conclusion

Altered estrogen biosynthesis signaling plays a role in SNIP pathogenesis, revealing distinct biomarkers that could serve as novel diagnostic markers and therapeutic targets for SNIP management.

Supporting Evidence

  • The estrogen biosynthesis pathway was significantly altered in both datasets.
  • Five key biomarkers were significantly altered in SNIP tissues.
  • Validation in an independent cohort confirmed elevated protein levels of these markers.

Takeaway

Researchers found new markers in tumors that can help doctors understand and treat a type of nose tumor better.

Methodology

RNA sequencing and tissue microarray analysis were used to identify and validate biomarkers in SNIP tissues.

Limitations

The study's primary limitation is the small sample size for the initial RNA-Seq analysis.

Participant Demographics

The average patient age was 50.20 years, with 83.7% male specimens.

Statistical Information

P-Value

<0.00001

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.7150/ijms.101753

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication